Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Department of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
J Adolesc Health. 2020 Aug;67(2):186-193. doi: 10.1016/j.jadohealth.2020.01.026. Epub 2020 Apr 5.
The aim of the study was to design and implement a novel, universally offered, computerized clinical decision support (CDS) gonorrhea and chlamydia (GC/CT) screening tool embedded in the emergency department (ED) clinical workflow and triggered by patient-entered data.
The study consisted of the design and implementation of a tablet-based screening tool based on qualitative data of adolescent and parent/guardian acceptability of GC/CT screening in the ED and an advisory committee of ED leaders and end users. The tablet was offered to adolescents aged 14-21 years and informed patients of Centers for Disease Control and Prevention GC/CT screening recommendations, described the testing process, and assessed whether patients agreed to testing. The tool linked to CDS that streamlined the order entry process. The primary outcome was the patient capture rate (proportion of patients with tablet data recorded). The secondary outcomes included rates of patient agreement to GC/CT testing and provider acceptance of the CDS.
Outcomes at the main and satellite EDs, respectively, were as follows: 1-year patient capture rates were 64.6% and 64.5%; 9.9% and 4.4% of patients agreed to GC/CT testing, and of those, the provider ordered testing for 73% and 72%.
Implementation of this computerized screening tool embedded in the clinical workflow resulted in patient capture rates of almost two-thirds and clinician CDS acceptance rates >70% with limited patient agreement to testing. This screening tool is a promising method for confidential GC/CT screening among youth in an ED setting. Additional interventions are needed to increase adolescent agreement for GC/CT testing.
本研究旨在设计并实施一种新颖的、普遍提供的计算机临床决策支持(CDS)淋病和衣原体(GC/CT)筛查工具,该工具嵌入在急诊部(ED)临床工作流程中,并通过患者输入的数据触发。
该研究包括基于 ED 中青少年和家长/监护人对 GC/CT 筛查的可接受性的定性数据,以及 ED 领导和最终用户顾问委员会,设计和实施基于平板电脑的筛查工具。该平板电脑提供给 14-21 岁的青少年,告知患者美国疾病控制与预防中心(CDC)的 GC/CT 筛查建议,描述检测过程,并评估患者是否同意检测。该工具与 CDS 链接,简化了订单录入过程。主要结果是患者捕获率(记录有平板电脑数据的患者比例)。次要结果包括患者同意 GC/CT 检测的比率和提供者对 CDS 的接受率。
主和卫星 ED 的结果分别为:1 年患者捕获率为 64.6%和 64.5%;9.9%和 4.4%的患者同意进行 GC/CT 检测,其中 73%和 72%的提供者为其开了检测单。
将这种嵌入临床工作流程的计算机化筛查工具付诸实施,导致患者捕获率接近三分之二,临床医生 CDS 接受率>70%,而患者同意检测的比例有限。这种筛查工具是在 ED 环境中对青少年进行保密 GC/CT 筛查的一种很有前途的方法。需要进一步的干预措施来提高青少年对 GC/CT 检测的同意率。